options
search icon
email icon
EN
rrss gif icons
twitter icon
linkedin icon youtube icon
shape

ANGELAB

Lab-on-a-chip technology to detect fetal genetic disorders in the maternal blood

ANGELAB

Participants

  • IK4-IKERLAN (coordinator)
  • HSG-IMIT RTD
  • ADEMTECH SME
  • OSAKIDETZA
  • Fundación Rioja Salud RTD
  • WUT RTD
  • CING RTD
  • NIPD SME
  • DNAdata SME
  • Biopharma SME
  • EV GroupLarge
  • GAIKER-IK4
  • BIODONOSTIA
  • CAN SME
  • POC microSOLUTIONS SME

Duration

2012-2016 Contract number: FP7-ICT-317635

Budget

11 429 587 €

Programme

European programmes: FP7-ICT


The project AngeLab (abbreviation of “A New GEnetic LABoratory for non-invasive prenatal diagnosis”) involves developing a family of devices based on lab-on-a-chip technology, able to detect foetus disorders by testing the mother’s blood.

The devices will separate and analyse foetal DNA in the maternal blood to determine whether the baby is suffering from any genetic disorders such as Down’s syndrome, cystic fibrosis or spinal muscular atrophy.

our contribution

IK4-Ikerlan was involved in creating the original AngeLab idea and also manages and pilots the project consortium. Our technical contribution consists of developing miniaturised labs-on-a-chip and integrating all the systems in a single device.

For more information check this video

Consulta toda la información sobre este proyecto en www.angelab-systems.eu

close overlay